CompletedNot Applicable

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)

United States447 participantsStarted 2023-03-06

Plain-language summary

This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 18 years of age or older at time of bronchoscopy. Scheduled for navigational bronchoscopy for the evaluation of a peripheral pulmonary lesion. Exclusion Criteria: Enrolled in a different study requiring use of one of these specific platforms (i.e., ILLUMISITE™ Platform (EMN) or Ion™ Endoluminal System (SSCB)). Subject declines to participate.

What they're measuring

Diagnostic Yield

Timeframe: 7 days post-enrollment

Trial details

NCT IDNCT05705544

SponsorVanderbilt University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-09

Results submitted2025-03-28

View on ClinicalTrials.gov More Peripheral Pulmonary Lesions trials